The Scotts Miracle-Gro Company
The Scotts Miracle-Gro Company (SMG) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for The Scotts Miracle-Gro Company (SMG), featuring income statements, balance sheets, and cash flow data.
The Scotts Miracle-Gro Company (SMG) Income Statement & Financial Overview
View the income breakdown for The Scotts Miracle-Gro Company SMG across both annual and quarterly reports.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $1.19B | $1.42B | $416.80M | $414.70M |
| Cost of Revenue | $810.00M | $873.10M | $322.00M | $444.20M |
| Gross Profit | $378.00M | $547.90M | $94.80M | -$29.50M |
| Gross Profit Ratio | $0.32 | $0.39 | $0.23 | -$0.07 |
| R&D Expenses | $16.70M | $9.10M | $7.60M | $9.40M |
| SG&A Expenses | $176.10M | $176.20M | $114.20M | $104.70M |
| Operating Expenses | $192.80M | $203.20M | $145.80M | $186.60M |
| Total Costs & Expenses | $1.003B | $1.08B | $467.80M | $630.80M |
| Interest Income | $0.00 | $0.00 | $0.00 | -$100000.00 |
| Interest Expense | $31.70M | $36.60M | $33.70M | $33.10M |
| Depreciation & Amortization | -$37.90M | $19.00M | $18.90M | $20.00M |
| EBITDA | $201.10M | $356.50M | -$43.30M | -$257.70M |
| EBITDA Ratio | $0.17 | $0.25 | -$0.10 | -$0.62 |
| Operating Income | $215.00M | $344.70M | -$51.00M | -$216.10M |
| Operating Income Ratio | $0.18 | $0.24 | -$0.12 | -$0.52 |
| Other Income/Expenses (Net) | -$7.70M | -$43.80M | -$44.90M | -$96.10M |
| Income Before Tax | $207.30M | $300.90M | -$95.90M | -$312.20M |
| Income Before Tax Ratio | $0.17 | $0.21 | -$0.23 | -$0.75 |
| Income Tax Expense | $58.20M | $83.40M | -$26.40M | -$68.20M |
| Net Income | $149.10M | $217.50M | -$69.50M | -$244.00M |
| Net Income Ratio | $0.13 | $0.15 | -$0.17 | -$0.59 |
| EPS | $2.60 | $3.78 | -$1.21 | -$4.29 |
| Diluted EPS | $2.59 | $3.72 | -$1.21 | -$4.29 |
| Weighted Avg Shares Outstanding | $57.50M | $57.50M | $57.30M | $56.90M |
| Weighted Avg Shares Outstanding (Diluted) | $58.60M | $58.40M | $57.30M | $56.90M |
The company's financials show resilient growth, with revenue advancing from $414.70M in Q4 2024 to $1.19B in Q3 2025. Gross profit remained healthy with margins at 32% in Q3 2025 compared to -7% in Q4 2024. Operating income hit $215.00M last quarter, sustaining a consistent 18% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $201.10M. Net income dropped to $149.10M, while earnings per share reached $2.60. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan